Our key areas for partnering and M&A opportunities are in the following therapeutic categories:

• Cough & cold and allergy
• Gastrointestinal disorders
• Pain and mobility
• Premium vitamin and mineral supplements
• Sore throat
• Leg Health products

Furthermore we are interested in the in-licensing of Rx-to-OTC switch candidates as well as in significant growth and acquisition opportunities outside the categories listed above.

Why partner with us:

• We strive to create trusting, long-term partnerships
• We have global reach
• A flexible and open-minded deal-making approach backed by our family shareholders. We aim to create win-win situations for both our partner and Boehringer Ingelheim CHC
• We have a highly experienced, dedicated, cross-functional team of global experts with a proven track record to make partnering a success

Dr. Oliver Freichel
Vice President Global Business Development CHC
Head of Business Development USA / Japan